Inovio Pharmaceuticals
INO
#9668
Rank
ยฃ68.57 M
Marketcap
ยฃ0.83
Share price
1.85%
Change (1 day)
-49.17%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ7.59 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is ยฃ7.59 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ9.45 M-60.13%
2023-12-31ยฃ23.71 M-10.56%
2022-12-31ยฃ26.51 M8.37%
2021-12-31ยฃ24.46 M-14.6%
2020-12-31ยฃ28.64 M-62.25%
2019-12-31ยฃ75.88 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31ยฃ7.48 M-9.39%
2008-12-31ยฃ8.26 M
2003-12-31ยฃ0.18 M1338.03%
2002-12-31ยฃ0.01 M-61.21%
2001-12-31ยฃ0.03 M
2001-03-31ยฃ0.08 M11.74%
2000-03-31ยฃ0.07 M19.96%
1999-03-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ41.66 B 548,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ35.60 B 468,932.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ48.28 B 635,915.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.80 B 221,192.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ37.21 B 490,079.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ19.12 B 251,755.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.74 B 9,774.64%๐Ÿ‡บ๐Ÿ‡ธ USA